GB202201069D0 - Treatment - Google Patents
TreatmentInfo
- Publication number
- GB202201069D0 GB202201069D0 GBGB2201069.8A GB202201069A GB202201069D0 GB 202201069 D0 GB202201069 D0 GB 202201069D0 GB 202201069 A GB202201069 A GB 202201069A GB 202201069 D0 GB202201069 D0 GB 202201069D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2201069.8A GB202201069D0 (en) | 2022-01-27 | 2022-01-27 | Treatment |
PCT/GB2022/052354 WO2023041927A1 (en) | 2021-09-16 | 2022-09-16 | Azd1656 for use in the treatment of pneumonitis or myocarditis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2201069.8A GB202201069D0 (en) | 2022-01-27 | 2022-01-27 | Treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202201069D0 true GB202201069D0 (en) | 2022-03-16 |
Family
ID=80621193
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2201069.8A Ceased GB202201069D0 (en) | 2021-09-16 | 2022-01-27 | Treatment |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202201069D0 (en) |
-
2022
- 2022-01-27 GB GBGB2201069.8A patent/GB202201069D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB202108224D0 (en) | Treatment | |
GB202016058D0 (en) | Therapeautic treatment | |
GB202003722D0 (en) | Treatment | |
GB202002711D0 (en) | Treatment | |
GB202319954D0 (en) | Treatment | |
GB202319658D0 (en) | Treatment | |
GB202319443D0 (en) | Treatment | |
GB202318845D0 (en) | Treatment | |
GB202311007D0 (en) | Treatment | |
GB202304853D0 (en) | Treatment | |
GB202218460D0 (en) | Treatment | |
GB202214206D0 (en) | Treatment | |
GB202212125D0 (en) | Treatment | |
GB202204288D0 (en) | Treatment | |
GB202204070D0 (en) | Treatment | |
GB202201069D0 (en) | Treatment | |
GB202212566D0 (en) | Combination treatment | |
GB202304716D0 (en) | New treatment | |
GB202210430D0 (en) | New treatment | |
GB202206219D0 (en) | New treatment | |
GB202208508D0 (en) | Novel treatment | |
GB202104666D0 (en) | COVID-19 treatment | |
GB202104416D0 (en) | Treatment reginmens | |
GB202103957D0 (en) | Treatment | |
GB202103122D0 (en) | Treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
COOA | Change in applicant's name or ownership of the application |
Owner name: EXCALIBUR MEDICINES LIMITED Free format text: FORMER OWNER: ST GEORGE STREET CAPITAL LIMITED |
|
AT | Applications terminated before publication under section 16(1) |